Skip to main content
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
Published Web Location
http://europepmc.org/articles/PMC4122675?pdf=renderNo data is associated with this publication.
Abstract
Deregulation of lysine methylation signalling has emerged as a common aetiological factor in cancer pathogenesis, with inhibitors of several histone lysine methyltransferases (KMTs) being developed as chemotherapeutics. The largely cytoplasmic KMT SMYD3 (S
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.